- The development of tissues in the laboratory could solve the problem of tissue availability for transplantation
- Scientists have found it difficult to develop tiny blood vessels called capillaries to nourish such tissues
- A new method suggested and tested by scientists could possibly overcome this problem
Bioengineers may be able to develop tissues with capillaries in the near future that could solve the problems associated with transplantation. A study indicating the same was published in the Biomaterials Science.
Organ transplantation saves several lives. During the surgical procedure, a tissue or an organ is obtained from a cadaver or sometimes, from another living person, as in kidney transplantation, which is then introduced into the recipient. Unfortunately, donor tissues are not always available. In addition, quite often, the transplanted organ gets rejected, further adding to the woes of the patient.
Scientists have tried to produce tissues in the laboratory to overcome the current difficulties associated with transplantation. The availability of such tissues will ensure an adequate supply to those who need them. Since the tissues will be made compatible with the patient's body, they will also avoid the problem of rejection. A branch of medicine referred to as tissue engineering or regenerative medicine uses stem cells to produce the tissues. The stem cells are cells that can be coaxed into developing into a particular type of cells by exposing them to a specific environment.
The capillaries are very thin walled, and contain a single layer of cells called the endothelial cells. This is in contrast to the arteries and the veins, which also contain a muscle layer surrounding the endothelial layer; the muscle layer is thicker in the arteries as compared to the veins. The muscle layer is surrounded by another layer consisting mainly of collagen.
When capillaries develop, they undergo a process called tubulogenesis, in which they assume the tubular shape of a blood vessel. The cells develop vacuoles that join together, leading to the formation of a tubular network through which blood can pass. This process is difficult to replicate in the laboratory.
Through their experiments, scientists found that it may now be possible to produce capillaries in the laboratory.
- They used induced pluripotent stem cells (iPSCs) to produce the endothelial cells of the capillaries. iPSCs can be produced from any adult, and are therefore specific for the patient. This could probably solve the problem of tissue rejection.
- They modified the cells to produce two types of fluorescent proteins, one in the nucleus and the other throughout the cell. With the help of these, they could study the cells under the microscope and monitor the changes going on in the cells.
- The cells were then mixed with fibrin, which is a natural medium, with or without another type of cell called the mesenchymal stem cells. They were incubated for a week. This procedure resulted in good tubulogenesis, irrespective of the presence or absence of the mesenchymal cells.
- Tubulogenesis was more difficult when the cells were incubated in a semisynthetic medium called gelatin methacrylate. This difficulty was overcome by the addition of mesenchymal stem cells. This finding is important since gelatin methacrylate has a great potential to be used for tissue engineering.
Moreover, the tissues, when constructed from the cells of a particular patient, can be used to test the best treatment option for that patient. Thus, the patient can be offered only the treatment that is more likely to work and cause the least side effects and be saved from the anguish, side effects and cost of treatments associated with a trial-and-error approach to the treatment of conditions like cancer.
- Calderon GA et al. Tubulogenesis of co-cultured human iPS-derived endothelial cells and human mesenchymal stem cells in fibrin and gelatin methacrylate gels. Biomater. Sci., (2017), Advance Article. DOI: 10.1039/C7BM00223H
Please use one of the following formats to cite this article in your essay, paper or report:
Dr. Simi Paknikar. (2017, July 14). Advances in Tissue Engineering may Overcome Difficulties in Transplantation. Medindia. Retrieved on Sep 28, 2022 from https://www.medindia.net/news/healthinfocus/advances-in-tissue-engineering-may-overcome-difficulties-in-transplantation-171653-1.htm.
Dr. Simi Paknikar. "Advances in Tissue Engineering may Overcome Difficulties in Transplantation". Medindia. Sep 28, 2022. <https://www.medindia.net/news/healthinfocus/advances-in-tissue-engineering-may-overcome-difficulties-in-transplantation-171653-1.htm>.
Dr. Simi Paknikar. "Advances in Tissue Engineering may Overcome Difficulties in Transplantation". Medindia. https://www.medindia.net/news/healthinfocus/advances-in-tissue-engineering-may-overcome-difficulties-in-transplantation-171653-1.htm. (accessed Sep 28, 2022).
Dr. Simi Paknikar. 2021. Advances in Tissue Engineering may Overcome Difficulties in Transplantation. Medindia, viewed Sep 28, 2022, https://www.medindia.net/news/healthinfocus/advances-in-tissue-engineering-may-overcome-difficulties-in-transplantation-171653-1.htm.